Better Therapeutics Inc (BTTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BTTX Annual Balance Sheets →
Looking at balance sheet data from Better Therapeutics Inc through Sep 30 2022 provides insight into Sep 30 2023's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2023)
(Jun 30 2023) (Mar 31 2023) (Dec 31 2022) (Sep 30 2022)
Assets
Cash & cash equivalent6.60
Cash & Short-term Investments6.00
Other Current Assets0.07
Prepaid Expense, Current AS0.67
Total Current Assets7.35
Equipment/Property/Plant Net0.10
Other Assets, Noncurrent3.00
Total Assets10.72
Liabilities
Accounts Payable, Current AC2.31
Employee-related Liabilities, Current AC1.89
Long-term Debt, Current Maturities LO6.59
Other Liabilities, Current2.16
Total Current Liabilities12.94
Long-term debt7.72
Total Long-term Debt7.72
Total Liabilities20.66
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock124.37
Retained Earnings / Accumulated Deficit-134.31
Other Equity0.00
Common Stockholder's Equity-9.94
Total Stockholder's Equity-9.94
Liabilities & Stockholder's Equity10.72
4 historic quarters locked

Sign in to unlock the full Better Therapeutics Inc balance sheet history.

About Better Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-23-061515

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.